OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
Peimin Chen, Ming‐Shyen Yen, Ko‐Jiunn Liu, et al.
Journal of Biomedical Science (2011) Vol. 18, Iss. 1
Open Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

Mesenchymal Stromal Cells: New Directions
Armand Keating
Cell stem cell (2012) Vol. 10, Iss. 6, pp. 709-716
Open Access | Times Cited: 746

Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review
Lucie Bačáková, Jana Zárubová, Martina Trávníčková, et al.
Biotechnology Advances (2018) Vol. 36, Iss. 4, pp. 1111-1126
Closed Access | Times Cited: 495

Articular fibrocartilage - Why does hyaline cartilage fail to repair?
Angela R. Armiento, Mauro Alini, Martin J. Stoddart
Advanced Drug Delivery Reviews (2018) Vol. 146, pp. 289-305
Open Access | Times Cited: 311

Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
Li‐Tzu Wang, Chiao-Hsuan Ting, Ming‐Shyen Yen, et al.
Journal of Biomedical Science (2016) Vol. 23, Iss. 1
Open Access | Times Cited: 293

Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells
Andreia Ribeiro, Paula Laranjeira, Sandrine Mendes, et al.
Stem Cell Research & Therapy (2013) Vol. 4, Iss. 5
Open Access | Times Cited: 246

Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study
R. Secunda, Rosy Vennila, A M Mohanashankar, et al.
Cytotechnology (2014) Vol. 67, Iss. 5, pp. 793-807
Open Access | Times Cited: 190

Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application
Carmen L. Insausti, Miguel Blanquer, Ana García, et al.
Stem Cells and Cloning Advances and Applications (2014), pp. 53-53
Open Access | Times Cited: 129

Progress of mesenchymal stem cell therapy for neural and retinal diseases
Tsz Kin Ng
World Journal of Stem Cells (2014) Vol. 6, Iss. 2, pp. 111-111
Open Access | Times Cited: 121

Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2
Pei-Min Chen, Ko‐Jiunn Liu, Pei-Ju Hsu, et al.
Journal of Leukocyte Biology (2014) Vol. 96, Iss. 2, pp. 295-303
Closed Access | Times Cited: 113

Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during ProlongedIn VitroExpansion: Considerations for Cytotherapy
Ioannis Christodoulou, Fragiskos N. Kolisis, D. Papaevangeliou, et al.
Stem Cells International (2013) Vol. 2013, pp. 1-12
Open Access | Times Cited: 103

The Role of Cathelicidin LL-37 in Cancer Development
Ewelina Piktel, Katarzyna Niemirowicz, Urszula Wnorowska, et al.
Archivum Immunologiae et Therapiae Experimentalis (2015) Vol. 64, Iss. 1, pp. 33-46
Open Access | Times Cited: 99

Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases
Melissa K. Jones, Bin Lü, Sergey Girman, et al.
Progress in Retinal and Eye Research (2017) Vol. 58, pp. 1-27
Open Access | Times Cited: 96

Significance of LL-37 on Immunomodulation and Disease Outcome
Binbin Yang, David A. Good, Tamim Mosaiab, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 90

Advances in Mesenchymal Stem Cell Therapy for Immune and Inflammatory Diseases: Use of Cell-Free Products and Human pluripotent Stem Cell-Derived Mesenchymal Stem Cells
Li‐Tzu Wang, Ko‐Jiunn Liu, Huey‐Kang Sytwu, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 9, pp. 1288-1303
Open Access | Times Cited: 89

Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells
Alfonso Eirin, Xiang-Yang Zhu, Amrutesh S. Puranik, et al.
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0174303-e0174303
Open Access | Times Cited: 87

Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes
Yicheng Qi, Jing Ma, Shengxian Li, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 86

Application of Stem Cell Therapy for Infertility
Sarama Saha, Partha Roy, Cynthia Corbitt, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1613-1613
Open Access | Times Cited: 62

Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks
Gaspare Cucinella, Giuseppe Gullo, Erika Catania, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 135-135
Open Access | Times Cited: 8

Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study
Ayşe Öner, Zeynep Burçin Gönen, Neslihan Sinim, et al.
Stem Cell Research & Therapy (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 81

Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases
Jun Liang, Huayong Zhang, Cheng Zhao, et al.
International Journal of Rheumatic Diseases (2017) Vol. 20, Iss. 9, pp. 1219-1226
Closed Access | Times Cited: 77

Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Audrey Cras, Dominique Farge, T. Carmoi, et al.
Arthritis Research & Therapy (2015) Vol. 17, Iss. 1
Open Access | Times Cited: 76

Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
Wei‐Bei Wang, Ming‐Shyen Yen, Ko‐Jiunn Liu, et al.
Stem Cell Reports (2015) Vol. 5, Iss. 3, pp. 392-404
Open Access | Times Cited: 70

The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets
Alper Tunga Özdemir, Rabia Bilge Özgül Özdemir, Cengiz Kırmaz, et al.
Cellular Immunology (2016) Vol. 310, pp. 108-115
Closed Access | Times Cited: 69

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19
B. Linju Yen, Ming‐Shyen Yen, Li-Tzu Wang, et al.
Stem Cells Translational Medicine (2020) Vol. 9, Iss. 10, pp. 1163-1173
Open Access | Times Cited: 69

Page 1 - Next Page

Scroll to top